Themed Parallel Session 3408

Answering Important Patient and Parent Questions in the Clinic

Tuesday, August 29, 2023
15:00 – 17:00

 

In this session, the faculty will discuss how clinical characteristics of patients, genotype and biomarkers can be used to predict and/or modify disease progression, treatment response and risk to offspring in Parkinson’s disease.

Chairs:
Victor Fung, Australia 
Litvan, USA

“What Does my Future hold?” Clues from Phenotype, Genetics, and Biomarkers on Disease Progression and How to Use Them in the Clinic 
Clemens Scherzer, USA 

“What is the Best Treatment for Me Right Now?” How Clinical, Pharmacogenetic and Other Factors Can Be Used to Predict Response to and Optimize Symptomatic Treatment in Parkinson’s Disease 
Rob De Bie, Netherlands 

“What About My Kids?” Genetic and Epigenetic Factors Influencing Inheritance in Parkinson’s Disease, and Potential for Modification 
Nicholas Wood, United Kingdom 

CSPC Liaison: 
Victor Fung, Australia

At the conclusion of this session, participants should be better able to:

1. Describe how phenotype, genetics, and biomarkers can be used to predict disease progression in Parkinson’s disease, both in the routine and research clinic
2. Discuss the clinical, pharmacogenetic and other factors can be used to predict response to and optimize symptomatic treatment in Parkinson’s disease
3. Recognize how genetic and epigenetic factors influence the hereditability of Parkinson’s disease, what and when to test, and what to advise patients and their children in the clinic

Recommended Audience:
Clinician, Researcher / Basic Scientist, Health Professional (non-physician), Fellow / Resident / Student, Industry

Education Level:
Beginner/Foundational, Intermediate/ Experienced